EC approval for post-steroid graft-versus-host treatment

Jakavi treats a potentially life-threatening condition which often effects transplant patients - News - PharmaTimes

Related Keywords

Germany ,Robert Zeiser ,Innovative Medicines International ,Committee For Medicinal Products Human ,University Hospital Freiburg ,European Commission ,Department Of Haematology ,Novartis ,Medicinal Products ,Human Use ,Stem Cell Transplantation ,Marie France Tschudin ,Novartis President ,Chief Commercial ,Agvhd ,Ost Steroid ,C ,